TERNS PHARMACEUTICALS INC's ticker is TERN and the CUSIP is 880881107. A total of 38 filers reported holding TERNS PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,018,733 | +310.9% | 997,760 | +614.8% | 0.00% | – |
| Q2 2023 | $1,221,413 | -27.3% | 139,590 | -1.7% | 0.00% | – |
| Q1 2023 | $1,680,523 | +814.2% | 141,936 | +686.0% | 0.00% | – |
| Q4 2022 | $183,831 | +337.7% | 18,058 | +149.3% | 0.00% | – |
| Q3 2022 | $42,000 | -8.7% | 7,243 | -61.2% | 0.00% | – |
| Q2 2022 | $46,000 | +84.0% | 18,671 | +119.9% | 0.00% | – |
| Q1 2022 | $25,000 | -96.0% | 8,491 | -90.5% | 0.00% | – |
| Q4 2021 | $632,000 | +133.2% | 89,456 | +243.5% | 0.00% | – |
| Q3 2021 | $271,000 | -17.6% | 26,044 | -2.9% | 0.00% | – |
| Q2 2021 | $329,000 | – | 26,831 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 1,099,309 | $13,015,819 | 9.59% |
| VR Adviser, LLC | 3,619,522 | $42,855,140 | 8.37% |
| Vivo Capital, LLC | 6,657,992 | $78,830,625 | 5.47% |
| Fairmount Funds Management LLC | 2,040,000 | $24,153,600 | 4.15% |
| Decheng Capital Management III (Cayman), LLC | 714,285 | $8,457,134 | 3.41% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 667,922 | $7,908,196 | 3.26% |
| Ikarian Capital, LLC | 721,341 | $8,540,677 | 1.94% |
| Orbimed Advisors | 7,619,135 | $90,210,558 | 1.77% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,448,275 | $40,827,576 | 1.72% |
| CROSSPOINT FINANCIAL, LLC | 12,054 | $142,719 | 1.54% |